SAN DIEGO – Resmed Inc. results for the quarter ended December 31, 2025 showed a revenue increase of 11% to $1.4 billion. Income from operations increased 18%.

“Our second quarter results demonstrate the strength and resilience of our global business as we continue advancing our mission to help people sleep better, breathe better, and live longer and healthier lives in the comfort of their own home,” said Mick Farrell, Resmed’s chairman and CEO. “Year-over-year, we delivered 11% headline revenue growth, 310 basis points of non‑GAAP gross margin expansion, and continued operating excellence, resulting in another quarter of mid-teens non‑GAAP EPS growth.

“These results reflect strong ongoing demand for our market‑leading sleep and respiratory care devices, as well as the growing impact of our digital health ecosystem that spans more than 140 countries,” Farrell continued. “As we move into the second half of fiscal year 2026, we will continue to invest in innovation to scale our digital health capabilities and expand global access to life-saving care, while delivering sustainable, profitable growth.”

Resmed (Booth #1021) is scheduled to exhibit at Medtrade, scheduled for March 2-4, 2026 at the Phoenix Convention Center.